# A. Michael Lincoff

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/a-michael-lincoff/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,280 |
| Field | Acute Myocardial Infarction Research |
| h-index | 119 |
| i10-index | 344 |
| Last Known Institution | Cleveland Clinic |
| OpenAlex ID | https://openalex.org/A5001994412 |
| ORCID iD | 0000-0001-8175-2121 |
| Works | 620 |

## Researcher papers

Showing 12 of 20.

- [Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/)
- [ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction](https://scholariq.org/papers/acc-aha-2007-guidelines-for-the-management-of-patients-with-unstable-angina-non/)
- [ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction](https://scholariq.org/papers/acc-aha-2007-guidelines-for-the-management-of-patients-with-unstable-angina-non-2/)
- [Bivalirudin for Patients with Acute Coronary Syndromes](https://scholariq.org/papers/bivalirudin-for-patients-with-acute-coronary-syndromes/)
- [Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.](https://scholariq.org/papers/pioglitazone-and-risk-of-cardiovascular-events-in-patients-with-type-2-diabetes/)
- [Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention](https://scholariq.org/papers/bivalirudin-and-provisional-glycoprotein-iib-iiia-blockade-compared-with-heparin/)
- [2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)](https://scholariq.org/papers/2012-accf-aha-focused-update-of-the-guideline-for-the-management-of-patients/)
- [Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk](https://scholariq.org/papers/effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse/)
- [Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation](https://scholariq.org/papers/predictors-of-outcome-in-patients-with-acute-coronary-syndromes-without/)
- [2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction](https://scholariq.org/papers/2012-accf-aha-focused-update-incorporated-into-the-accf-aha-2007-guidelines-for/)
- [Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients](https://scholariq.org/papers/bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/)
- [Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease](https://scholariq.org/papers/evacetrapib-and-cardiovascular-outcomes-in-high-risk-vascular-disease/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Cleveland Clinic](https://scholariq.org/institutions/cleveland-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.